|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS |
 | |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
Video: 6-24-09 - Dow 30 stocks Buy-Sell-Hold Ratings
11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for NOVARTIS AG ADS (NYSE:NVS) Stock.
NVS stock opening price was $53.08 per share.
Current price of NYSE:NVS Stock is $53.24 per share
and it is
$+0.44, (+0.83%) today
and it was trading in the daily range of $52.80 - 53.43 per share.
Current Bid Price for (NYSE:NVS) stock is $50.80 and the Ask Price is $53.30. In the last 52 weeks
NVS stock was trading in the range of $33.34 - 53.81. 50-Day Moving Average for (NYSE:NVS) stock is
$51.2954 and 200-Day Moving Average is $44.8745. On average analysts predict that One Year Target Estimated price for
(NYSE:NVS) stock is $57.59.
NOVARTIS AG ADS (NYSE:NVS) Market capitalization is $120.9B. (NYSE:NVS) stock average daily volume is
1,321,900 shares per day.
However, on last trading session of Nov 13, 2009
NVS stock traded 547,049 shares.
Also The Short Ratio for (NYSE:NVS) stock is 3.90.
On previous trading session NVS Stock closed at $52.80 per share.
Last year NOVARTIS AG ADS (NYSE:NVS) before taxes (EBITDA) (ttm) earned $11.239B on total revenue of $42.306B.
Earnings Per Share - EPS (ttm) for NVS stock is 3.34.
Also, (NYSE:NVS) Stock Price Per Earnings ratio - P/E is 15.81.
Thus, (NYSE:NVS) Stock Price/Sales (ttm) ratio is 2.83 and Price/Book (mrq) ratio is 2.25.
(NYSE:NVS) Stock pays a dividend of $1.72 per share which is a yield of 3.26%.
So at this time (NYSE:NVS) Stock maintains Trailing Annual Dividend Rate at 1.72
.
StockRing Recommendations for NOVARTIS AG ADS (NYSE:NVS) Stock are updated daily here
http://www.StockRing.com/sr/StockDetail.asp?StockName=NVS
If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com.
|
NVS Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
 | |
| 1 Year Dow Jones Chart |
1 Year S&P 500 Chart |
 |
 |
| 1 Year Nasdaq Chart |
1 Year Canada Chart |
 |
 |
|
| |
| 5 Days Dow Jones Chart |
5 Days S&P 500 Chart |
 |
 |
| 5 Days Nasdaq Chart |
5 Days Canada Chart |
 |
 |
|
NVS Stock Charts: 1d 5d 3m 6m 1y 2y 5y Max News
Options! More Info
|
| Last Trade: |
53.24 |
| Trade Time: |
Nov 13 |
| Change: |
+0.44, (+0.83%) |
| Prev Close: |
52.80 |
| Open: |
53.08 |
| Bid: |
50.80 |
| Ask: |
53.30 |
| 1y Target Est: |
$57.59 |
| 50-Day Moving Average: |
51.2954 |
200-Day Moving Average:
|
44.8745 |
| Short Ratio: |
3.90 |
| Trailing Annual Dividend Rate: |
1.72
|
|
| Day's Range: |
52.80 - 53.43 |
| 52wk Range: |
33.34 - 53.81 |
| Volume: |
547,049 |
| Avg Vol: |
1,321,900 |
| Market Cap: |
120.9B |
| P/E (ttm): |
15.81 |
| EPS (ttm): |
3.34 |
| Div & Yield: |
1.72 (3.26%) |
| Revenue (ttm): |
42.306B |
| Earnings before Tax (EBITDA) (ttm): |
11.239B |
| Price/Sales (ttm): |
2.83 |
| Price/Book (mrq): |
2.25 |
|
Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!!
|
|
|
|
EUROs for $1 DOLLAR: 3 MONTHS | |
| |
|
NOVARTIS AG ADS (NYSE: NVS) Company Information
Novartis AG
Lichtstrasse 35
Basel, 4056
Switzerland - Map
Phone: 41 61 324 11 11
Fax: 41 61 324 80 01
Web Site: http://www.novartis.com
NOVARTIS AG ADS (NYSE: NVS) DETAILS
NOVARTIS AG ADS (NYSE: NVS) Index Membership: N/A
NOVARTIS AG ADS (NYSE: NVS) Sector: Healthcare
NOVARTIS AG ADS (NYSE: NVS) Industry: Drug Manufacturers - Major
NOVARTIS AG ADS (NYSE: NVS) Full Time Employees: 99,000
NOVARTIS AG ADS (NYSE: NVS) BUSINESS SUMMARY
Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare products worldwide. Its Pharmaceuticals division engages in the research, development, manufacture, distribution, and sale of pharmaceuticals in various therapeutic areas, including cardiovascular and metabolism; oncology; neuroscience and ophthalmics; respiratory; and immunology and infectious diseases. The company?s Vaccines and Diagnostics division offers preventive vaccine treatments and diagnostic tools. It provides influenza, meningococcal, pediatric, and traveler vaccines; and blood testing and molecular diagnostics to prevent the spread of infectious diseases. The company?s Sandoz division offers drugs, as well as pharmaceutical and biotechnological active substances. This division provides active ingredients and finished dosage forms of pharmaceuticals; anti-infectives; protein or biotechnology-based products; and biotech manufacturing to other companies on a contract basis. Its Consumer Health division consists of three business units: over-the-counter medicines (OTC), Animal Health, and CIBA Vision. OTC offers over-the-counter self medications. Animal Health provides veterinary products for farm and companion animals. CIBA Vision manufactures contact lenses and lens care products. Novartis AG has strategic alliance with Intercell AG to develop vaccines; CombinatoRx Incorporated to discover anti-cancer combinations; Ablynx NV for the discovery and development of Nanobody-based therapeutics; and MorphoSys AG. It also has research and development collaboration agreements with EpiStem Holdings Plc; Euroscreen S.A.; Nuevolution A/S; and Locus Pharmaceuticals, Inc. The company was founded in 1895 and is headquartered in Basel, Switzerland.
NOVARTIS AG ADS (NYSE: NVS) KEY EXECUTIVES SALARIES and BONUSES
Dr. Daniel L. Vasella M.D., Age: 55
Chairman and Chief Exec. Officer Salary: $ 2.95M Bonus: N/A
Dr. Raymund Breu Ph.D., Age: 63
Chief Financial Officer Salary: $ 1.08M Bonus: N/A
Dr. Joerg Reinhardt Ph.D., Age: 52
Chief Operating Officer Salary: $ 926.00K Bonus: N/A
Dr. Joseph Jimenez MD MBA CSCS, Age: 49
Chief Exec. Officer of Pharmaceuticals Division Salary: $ 2.10M Bonus: N/A
Mr. Mark C. Fishman M.D., Age: 58
Pres of Institutes for BioMedical Research (NIBR) Salary: $ 949.00K Bonus: N/A
|
1. Dow Jones Index - 30 Stocks on 11/12/2009: Buy
93% or 28 Hold
7% or 2 Sell
0% or 0 stocks
2. World Markets - 72 Indexes on 11/11/2009: Buy
63% or 44 Hold
21% or 15 Sell
16% or 11 indexes
3. Best Brands - 200 stocks on 11/12/2009: Buy
76% or 152 Hold
17% or 33 Sell
7% or 14 stocks
4. Hot News - 200 stocks on 11/8/2009: Buy
47% or 93 Hold
23% or 46 Sell
30% or 60 stocks
5. Big Movers - 200 stocks on 11/14/2009: Buy
69% or 137 Hold
23% or 47 Sell
8% or 15 stocks
6. Top Hitters - 200 stocks on 11/11/2009: Buy
77% or 153 Hold
15% or 31 Sell
8% or 15 stocks
7. S&P 500 Index - 500 Stocks on 7/21/2009:
Buy
68% or 341 Hold
21% or 106 Sell
11% or 53 stocks
8. S&P 400 Mid Cap - 400 Stocks on 7/21/2009: Buy
73% or 292 Hold
15% or 61 Sell
12% or 47 stocks
9. S&P 600 Small Cap - 600 Stocks on 4/18/2009: Buy
66% or 395 Hold
26% or 156 Sell
8% or 49 stocks
10. Nasdaq Telecom - 164 Stocks on 7/24/2009: Buy
49% or 81 Hold
35% or 56 Sell
16% or 27 stocks
11. Nasdaq Computer - 440 Stocks on 7/22/2009: Buy
60% or 263 Hold
26% or 115 Sell
14% or 62 stocks
12. Nasdaq Finance - 180 Stocks on 7/24/2009: Buy
61% or 109 Hold
6% or 12 Sell
33% or 59 stocks
13. NYSE International - 100 Stocks on 7/21/2009: Buy
58% or 58 Hold
34% or 34 Sell
8% or 8 stocks
14. Legg Mason Mutual - 346 Funds on 10/6/2009: Buy
38% or 133 Hold
51% or 176 Sell
11% or 37 funds
15. T. Row Price Mutual - 161 Funds on 10/6/2009: Buy
52% or 84 Hold
46% or 73 Sell
2% or 4 funds
16. London FTSE 100 - 94 Stocks on 4/1/2009: Buy
20% or 19 Hold
50% or 47 Sell
30% or 28 stocks
17. Canada Toronto - 209 Stocks on 4/18/2009: Buy
53% or 111 Hold
34% or 70 Sell
13% or 28 stocks
TOTAL RATINGS:
Buy
60% or 2493 Hold
27% or 1080 Sell
13% or 517 stocks
The Week In Review: The Bull In China's R&D Shop
istockAnalyst.com - 13 hours ago
Last week, a number of news items underscored the growing importance of China to the world's life science industry -- a bullish outlook for China's R&D. A Thompson Reuters report showed that China ...
|
|
Diversify Away With EFA!istockAnalyst.com (press release)Novartis (NVS), the Swiss drug giant, is pumping $1.25 billion to build two R&D centers in China. Global markets are functioning normally and they might ...and more » |
|
|
No comments:
Post a Comment